A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

There was no effect of insulin in the larger cohort using the second device. In a subsequent Phase 2 study to determine how much insulin entered the brain after nasal delivery, 19 people received 40 ...

Tanning nasal spray contains what is known as melanotan II, an ingredient that causes the skin to become more tan when exposed to ultraviolet (UV) light. Melanotan II is not approved for any use and ...

Lotions and sprays can be effective if used properly. However, applying enough spray to all needed areas can be difficult. Ultraviolet (UV) radiation from the sun can cause painful sunburn and lead to ...

Intervention: Two equal groups received either betamethasone 1mg orally (n = 21 ... Results: Headache, facial pain, nasal congestion and dizziness improved significantly from baseline in the ...